The Business Research Company’s Intravenous Immunoglobulin Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Intravenous Immunoglobulin Global Market Report 2023 evaluates intravenous immunoglobulin market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp

The global intravenous immunoglobulin market size is expected to grow from $12.86 billion in 2022 to $13.75 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the intravenous immunoglobulin market is expected to grow to $17.95 billion in 2027 at a CAGR of 6.9%.

The increasing geriatric population is expected to drive the intravenous immunoglobulin market forward. The geriatric population refers to the population above 65 years of age. As people grow old, their immunity does not work properly and there is a lack of antibodies. Therefore, they need immunoglobulins to provide them with antibodies. This increases demand for intravenous immunoglobulins and drives the intravenous immunoglobulin market forward. For instance, in 2021, according to the Elderly in India 2021 report by the National Statistical Office (NSO), a statistics wing of the Ministry of Statistics and Programme Implementation of the government of India, in 2021, 138 million elderly people were there in India and the number is expected to rise to 194 million by 2031. Additionally, according to the World Health Organization (WHO), a specialized agency of the United Nations, by 2030, 1 in 6 people in the world will be 60 years or older and the total number of people over 60 years will increase to 1.4 billion by 2030 increasing from 1 billion in 2020. As a result, the increasing geriatric population will drive the growth of the intravenous immunoglobulin market forward.

Get More Information On The Intravenous Immunoglobulin Market Report:

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

The intravenous immunoglobulin market segments in the report are:

1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)



2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels



3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications



4) By End-User: Hospitals, Clinics, Home Care

The table of contents in TBRC’s intravenous immunoglobulin market report includes:

Executive Summary
Intravenous Immunoglobulin Market Characteristics
Intravenous Immunoglobulin Market Trends And Strategies
Intravenous Immunoglobulin Market - Macro Economic Scenario
Intravenous Immunoglobulin Market Size And Growth
.

.

.

Africa Intravenous Immunoglobulin Market
Intravenous Immunoglobulin Market Competitive Landscape And Company Profiles
Key Mergers And Acquisitions In The Intravenous Immunoglobulin Market
Intravenous Immunoglobulin Market Future Outlook and Potential Analysis
Appendix
Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293



Email: [email protected]



Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model